AbbVie makes $63 billion bid for Botox maker Allergan

AbbVie makes $63B bid for Botox maker Allergan | AP News

Facing competition for the world's top-selling drug, AbbVie will spend about $63 billion to buy Botox maker Allergan as it attempts to spur ...

Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal

The drugmaker AbbVie said on Tuesday that it planned to buy Allergan, the maker of Botox, for about $63 billion, in one of the biggest mergers in the health ...

AbbVie looks beyond Humira with $63 billion deal for Botox-maker ...

Drugmaker AbbVie Inc said on Tuesday it would acquire Allergan Plc for about $63 billion, giving AbbVie control over the lucrative wrinkle ...

AbbVie makes $63-billion bid to buy Botox maker Allergan

AbbVie is to pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. That amounts to $188.24 a share, a 45% premium to ...

AbbVie makes $63B bid for Botox maker Allergan - The Detroit News

Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid ...

Abbvie Drops by a Record as Allergan Deal Fails to End Doubts

AbbVie Inc. agreed to pay $63 billion for rival drugmaker Allergan Plc, the latest merger in an industry where some of the biggest companies have been willing ...

AbbVie makes $63B bid for Botox maker Allergan

Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid ...

AbbVie Strikes Deal to Acquire Allergan for About $63 Billion - WSJ

As of Monday's close, Botox maker Allergan has a market capitalization of $42.47 billion. ... deal making have dwindled along with the ...

AbbVie makes $63B bid for Botox maker Allergan

Facing competition for the world's top-selling drug, AbbVie will spend about $63 billion to buy Botox maker Allergan as it attempts to spur future growth.

AbbVie is nearing a deal to buy Allergan for more than $60 billion

Drugmaker AbbVie said on Tuesday it would buy Botox-maker Allergan for about $63 billion, grabbing control of by far the biggest name in medical aesthetics.

AbbVie Makes $63B Bid for Botox Maker Allergan - NBC Bay Area

AbbVie is buying Botox maker Allergan in a cash-and-stock deal valued at about $63 billion. The maker of the blockbuster immune disorder ...

Humira maker AbbVie to acquire Botox maker Allergan for $63 billion

The deal comes as the latest in a string of acquisitions for the pharmaceutical industry. Other companies making deals recently have included ...

Looking for growth, AbbVie makes $63B bid for Botox maker Allergan

The specialty drug company AbbVie will spend $63 billion to acquire Allergan, the maker of Botox and other cosmetic treatments.

AbbVie makes $63B bid for Botox maker Allergan

The specialty drug company AbbVie will spend $63 billion to acquire Allergan, the maker of Botox and other cosmetic treatments.

AbbVie to Purchase Botox Maker Allergan in $63 Billion Deal

Jun.25 -- AbbVie Inc. agreed to buy Allergan Plc in a $63 billion deal that unites the rival drug makers in a bid for growth.

AbbVie to buy Botox maker Allergan for $63B - MedCity News

The company that makes Botox is the subject of the latest biopharma mega-deal. Chicago-based AbbVie said Tuesday it would acquire ...

AbbVie to Purchase Botox Maker Allergan in $63 Billion Deal

AbbVie Inc. agreed to buy Allergan Plc in a $63 billion deal that unites the rival drug makers in a bid for growth.

Maker Of Botox Is Sold To AbbVie In $63 Billion Deal

The drugmaker AbbVie, owner of the top-selling drug Humira, announced on Tuesday, June 25, it will buy Allergan for $63 billion, which makes this the ...

AbbVie makes $63 billion bid for Botox maker Allergan

Allergan was long based in Orange County until it was acquired in 2014 by Actavis Plc for $66 billion.

AbbVie makes $63 billion bid for Botox maker Allergan - Mint

The maker of the global blockbuster immune disorder treatment Humira will pay $120.30 in cash and a portion of AbbVie stock for each ...